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a b s t r a c t
Urothelial cells are specialized epithelial cells in the bladder that serve as a barrier toward excreted
urine. The urothelium consists of superﬁcial cells (most differentiated cells), intermediate cells, and basal
cells; the latter have been considered as urothelium progenitor cells. In this study, BrdU or EdU was
administrated to pregnant mice during E8–E13 for 2 consecutive days when bladder development
occurs. The presence of label retaining cells was investigated in bladders from offspring. In 6 months old
mice 1% of bladder cells retained labeling. Stem cell markers as deﬁned for other tissues (e.g., p63,
CD44, CD117, trop2) co-localized or were in close vicinity to label retaining cells, but they were not
uniquely limited to these cells. Remarkably, label retaining cells were distributed in all three cell layers
(p63þ , CK7þ , and CK20þ) of the urothelium and concentrated in the bladder trigone. This study
demonstrates that bladder progenitor cells are present in all cell layers and reside mostly in the trigone.
Understanding the geographic location of slow cycling cells provides crucial information for tissue
regenerative purposes in the future.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Urothelial cells are specialized epithelial cells in the bladder
that serve as a barrier toward excreted urine and are derived from
the endoderm (Mendelsohn, 2009). The urothelium consists of
three cell layers: the superﬁcial cell layer with the most differ-
entiated cells, the intermediate cell layer, and the basal cell layer.
During voiding or after damage of the bladder, bladder stem cells
and bladder progenitor cells regenerate and repair all cell layers
(Jost, 1989; Kreft et al., 2005; Khandelwal et al., 2009; Shin et al.,
2011). The residence of bladder stem cells or progenitor cells is still
under discussion (Gandhi et al., 2013).
Stem cells divide asymmetrically to transit amplifying cells and
stem cells. Transit amplifying cells give rise to intermediate and
superﬁcial cells, thus forming a complete epithelium (Slack et al.,
2000). Traditionally epithelial stem cells reside in the basal cell
layers. For example, stem cells have been identiﬁed cells in the
basal cell layer of skin, prostate, and limbal (Bickenbach, 1981;
Tsujimura et al., 2002; Cotsarelis et al., 1989). Scientists in the ﬁeld
of tissue engineering are aiming to engineer tissues to restore and
maintain normal function in diseased and injured tissues. The use
of adult stem cells for tissue engineering applications is promising,
and it is obvious that it is important to deﬁne the residence of
these cells.
Based on label retaining study with rat bladders, potential
progenitors cells of the bladder have been suggested to reside in
the basal cell layer (Kurzrock et al., 2008). In addition, in vivo cell
lineage analysis has shown that p63-expressing cells (basal cells)
are able to reproduce all epithelial lineages during development
(Pignon et al., 2013). In one of the few human studies multiple
stem cell-related clonal units were described in the basal cell layer
suggesting that basal cells maintain the capacity to turnover in
ageing (Gaisa et al., 2011). Furthermore, after injury sonic hedge-
hog (shh) expressing cells reside in basal cell layer shift from
quiescent cells to highly proliferative cells (Shin et al., 2011). Shh is
considered as a signal pathway that controls proliferation of stem
cells (Liu et al., 2006). However, one of the latest studies suggests
that bladder progenitor cells which differentiate to superﬁcial cells
in the adult bladder are intermediate cells (Foxa2þ p63þ Shhþ
Upkþ Krt5) (Gandhi et al., 2013). In airway epithelia supra-basal
cells (luminal secretory cells) can reprogram to multipotent stem
cells and repair epithelial injury (Tata et al., 2013). Collectively, it
appears that stem/progenitor cells may reside outside the basal
compartment.
The aim of this study was to identify bladder progenitor cells using
the thymidine-analogues BrdU (5-Bromo-20-deoxy-uridine) or EdU
(5-ethynyl-20-deoxyuridine), to label slow cycling cells. Label-retaining
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studies have been successful in identifying potential epithelial stem
cells in skin, intestine, and the endometrium of the uterus (Braun et al.,
2003; Barker et al., 2007; Gargett and Chan 2006). In contrast to
haematopoietic stem cells, these potential epithelial stem and pro-
genitor cells retain the analogue for a long period because they are
mostly quiescent and rarely divide (Slack, 2000; Kiel et al., 2007; Jost,
1986). DNA analogues were injected at the gestational days when
bladder development occurs to ensure labeling of all potential
progenitors. EdU/BrdU retaining cells were observed in all three cell
layers of the urothelium throughout life of the animals, suggesting that
progenitor cells shifted from the basal compartment towards the
luminal compartment. Moreover, label-retaining cells were concen-
trated in the trigone of the bladder, the area where the ureters and
urethra join the bladder and particularly present in close vicinity of the
urethra.
Materials and methods
Animals
All procedures involving animals were reviewed and approved
by the Animal Ethics Committee (DEC), Radboud University
Nijmegen. 16 weeks old CD-1 mice (14 females) were obtained
from Harlan Laboratories (Horst, the Netherlands). EdU (5-ethynyl-
20-deoxyuridine, mw. 252.2) was purchased from Invitrogen
(Carlsbad, US). BrdU (5-Bromo-20-deoxy-uridine, mw. 307.1) was
purchased from Roche (Basel, Switzerland). Pregnant mice were
divided into three groups (see Fig. 1). EdU (50 mg/g, dissolved in
phosphate buffered saline (PBS)) was injected subcutaneously into
the posterior neck to pregnant mice during 2 consecutive days on
E8þE9 (group A, n¼5), E10þE11 (group B, n¼4), and E12þE13
(group C, n¼5). BrdU (50 mg/g, dissolved in PBS) was injected
subcutaneously to pregnant mice during 2 consecutive days on
E12þE13 (n¼3). On E17, one mother from each group was killed
and the embryos were euthanized. Embryonic bladders were
collected. In short, bladders and the remains of the embryos were
collected in medium [RPMI-1640, 10% (v/v) FCS, 1% (v/v) P/S, and
1% (v/v) fungizone (Gibcos, Carlsbad, USA)], ﬁxed in 4% parafor-
maldehyde (PFA) and parafﬁn embedded or embedded in O.C.T.
compound (Tissue-Tek, Sakura, the Netherlands) and snap frozen
(Staack et al., 2003). The bladders from the offspring were
collected 5 days post-natally (p5, N¼15), 1 month (N¼6), 3 months
(N¼5), and 6 months post-natally (N¼9). Additionally, 3 bladders
from mother mice were collected. Tissues from the killed mice
were embedded in O. C. T. compound (Tissue-Tek) and snap frozen
or ﬁxed in 3% PFA and parafﬁn embedded. At each time point, at
least 3 animals were analyzed.
Immunohistochemical analysis (IHC)
Parafﬁn sections (4 mm) were deparafﬁnized in xylene and
rehydrated in gradient ethanol. Frozen sections (5 mm) were ﬁxed
with methanol at 21 1C for 10 min. Parafﬁn embedded and frozen
tissues were used for EdU and BrdU staining. Parafﬁn embedded
tissues were used for CK7, CK14, CK20, p63, ki67, β-catenin, nestin,
and LGR5. Frozen tissues were used for CD44, CD117, CD133,
and trop2.
For antigen retrieval, slides were boiled in EDTA buffer (1 mM,
pH 9; to enhance signals of EdU in parafﬁn embedded tissues) or
in sodium citrate buffer (10 mM, pH 6; to enhance signals of BrdU
in parafﬁn embedded tissues) for 10 min and cooled down to
21 1C. For CD117, no heat treatment was needed. EDTA buffer was
used for CK7, CK14, CK20, ki67, p63, and LGR5. Citrate buffer was
used for CK7, CK14, CK20, β-catenin, CD44, CD133, and trop2.
For mouse antibodies or double labeling with mouse anti BrdU,
mouse on mouse blocking reagent (M. O. M., Vector Labs, US) was
applied to prevent unspeciﬁc biding according to the manufac-
turer’s instruction. Endogenous peroxidase activity was blocked
with PBS (pH 7.4) containing 0.3% H2O2/0.1% NaN3 for 15 min. Non
speciﬁc binding was blocked with 10% normal serum from donkey,
sheep, or goat, depending on the secondary antibody in PBS as
appropriate for 1 h in a humid chamber at 21 1C.
Slides were incubated with primary antibodies, (see Table 1)
either PBS, or only secondary antibody (negative controls), fol-
lowed by either vectors red, DAB (Bright-DAB, Immunologic, the
Netherlands), or Alexa Fluor conjugates (see Table 1). For double
staining, slides were treated as described below. DNA was counter
stained with DAPI or hematoxyline.
BrdU staining
Slides were incubated with 1N HCL on ice for 10 min, trans-
ferred to 2 N HCl and incubated for 10 min at 21 1C, followed by
incubation with 2 N HCl at 60 1C for 30 min. Finally the slides were
neutralized with borate buffer, 0.1 M, pH 8.5, for 12 min at 21 1C.
Slides were incubated in 0.5% Triton X-100 in PBS for 20 min at
21 1C for cell permeabilization.
EdU staining
EdU staining was performed with the Click-iT EdU imaging kit
(Invitrogen) according to the manufacturers’ protocol. Slides were
washed twice with 3% bovine serum albumin (BSA) in PBS and
then incubated with the cocktail solution containing reaction
buffer, CuSO4, Alexa Fluor 594 Azide, and reaction additive for
1 h and protected from light. Slides were washed three times with
PBS before mounting with DAPI mount media (Invitrogen).
Slides were evaluated with ﬂuorescence microscope (LEICA DC
300F, Germany) and scanned with high content microscope (LEICA
DMI6000B, Germany). The percentage of positive cells was deter-
mined by manual counting. At each time point, at least 3 animals
were analyzed. To calculate the percentage of double positive cells
with a particular phenotype the number of double positive cells
was divided by the number of marker-positive cells within a
particular cell layer.
Results
Label retaining cells (RC) in vivo
The percentage of RC and the expression of RC in urothelium at
different cell layers from the offspring are summarized in
Tables 2 and 3. Expression of several stem cell and lineage markers
(e.g., Trop2, CD44, cytokeratins) was examined to co-localize
RC cells.
Fig. 1. Overview of BrdU or EdU injections (arrows) and day of pregnancy. Crosses
indicate sacriﬁce of animals. E¼embryonic days; p5¼post natal day 5; 1 m, 3 m,
and 6 m: 1, 3, and 6 months postnatally.
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RC in bladders at E17
RC in bladder at E17 were distributed throughout the develop-
ing bladder with more RC in close vicinity to the urethra. More
than 45% of the urothelial cells (all cell layers) contained EdU. RC
were CK7þ (Fig. 2a and enlarged in (b)), CK14þ (Fig. 2i), CK20þ
(Fig. 2g) and p63þ (Fig. 2h) in the urothelium. CK14 was only
expressed in the area close to the urethra. 56% of urothelia were
ki67þ and 13% of urothelia were ki67þ EdUþ . These ki67þ
EdUþ cells (Fig. 2c and enlarged in (d)) were possibly representing
highly proliferating cells in S phase. Trop2 was expressed
homogeneously in all urothelial cells at E17 (Fig. 2j). Membranous,
homogeneous CD44 expression was observed underneath the
basal cells (Fig. 2e and enlarged in (f)). Stronger intensity of
CD44 was observed close to the urethra.
RC at p5
In bladders from p5 the amount of RC in the urothelium was
reduced to 11%. RC were concentrated close to the trigone (Fig. 3a)
and the cross section of the urethra showed that RC were present
in all urothelial cell layers (Fig. 3b). RC were dual-labeled with
CK20 (luminal, Fig. 3c), CK7 and Trop2 (intermediate, Fig. 3d and
e), CK14, CD44, and ki67 (basal, Fig. 3f–h). CK14þ cells appeared
to be restricted to the basal cells, with the vast majority of basal
cells expressing CK14 (66.4%) and 32.3% of all urothelia. Only 0.4%
of ki67þ EdUþ cells were present in the basal layer of urothelia.
Trop2 was homogenously expressed in the intermediate and basal
cells at p5 and beyond, but the superﬁcial cells were Trop2-
negative. CD133 expression was absent (Supplementary informa-
tion 1, SI 1). LGR5 was expressed in umbrella cells (SI1). CD44 was
expressed predominantly by the basal cells. CD117 was exclusively
expressed in the stroma and was not restricted to EdU.
RC in bladders from 1 month old mice
RC in bladders from 1month old mice were distributed throughout
the urothelium, including luminal (Fig. 4b, c, f and g), intermediate
(Fig. 4c–e, and g), and basal (Fig. 4e and i) cells. RC were concentrated
in the trigone (Fig. 4a). The amount of RC in the urothelium was
reduced to 2.8%. The number of CK14-expressing cells decreased
signiﬁcantly in comparison to p5 to less than 8% of urothelia. No
ki67þ EdUþ cells were detected (Fig. 4h). Only 1.5% of the urothelial
cells were EdUþTrop2þ , but trop2 was not speciﬁc to RC. None of the
RC was CD117þ . EdUþ CD44þ were detected in approximately 4% of
cells in the connective tissue sustaining the urothelium, but EdUþ
CD44þ cells were not detected in the urothelium. CD44 appeared to
be restricted to the basal cells of the urothelium. Trop2 and β-catenin
(SI 1) were homogenously expressed in the intermediate and basal
cells of urothelia. Nestin or CD133 expression was not observed.
Table 1
Summary of primary and secondary antibodies.
Name Source Clone Origin Dilution or concentration
BrdU-POD Roche BMG 6H8 Mouse 1:10, 1.5 U/mL
BrdU-biotin Abcam Polyclonal Sheep 1:200, 6.5 μg/mL
Cytokeratin 7 (CK7) EuroProxima RCK105 Mouse 1:10, NA
Cytokeratin 14 (CK14) Thermo LL002 Mouse 1:100, 2 μg/mL
Cytokeratin 20 (CK20) ImmunoLogic – Rabbit 1:100, 2 μg/mL
p63 Dako 4A4 Mouse 1:100, 5.9 μg/mL
ki67 Thermo - Rabbit 1:200, NA
trop2 R&D AF1122 Goat 1:20, 5 μg/mL
CD44 BD IM7 Rat 1:100, 5 μg/mL
CD117 Millipore ACK2 Rat 1:100, 5 μg/mL
CD133 eBioscience 13A4 Rat 1:50, 10 μg/mL
β-Catenin BD 14 Mouse 1:1600, NA
Nestin Millipore Rat-401 Mouse 1:100, 10 μg/mL
G protein-coupled Receptor GPR 49 MBL Lgr5 Rabbit 1:400, 2.5 ng/mL
Alexa Fluor 488 or 594 Invitrogen – Goat 1:200, 10 μg/mL
Alexa Fluor 488 Invitrogen – Donkey 1:200, 10 μg/mL
Alexa Fluor 488 or 594 Invitrogen – Donkey 1:1000, 2 μg/mL
Alexa Fluor 488 Invitrogen – Donkey 1:200, 10 μg/mL
Vectors red Vector Laboratories – – –
DAB Immunologic – – –
Table 2
The percentage of label retaining cells in urothelial cells at different ages of
offspring. nPercentage of double positive cells of the cell population with a
particular phenotype within a cell layer. The number of double positive cells was
divided by the number of marker-positive cells. For instance: EdUþCK20þ/SC
refers to the number of EdUþCK20þ cells of the CK20þ population in the
superﬁcial cell layer.
Groups E17 p5 1 month 6 months
EdUþ in UC (%) 45.1% 11.4% 2.8% 1.2%
EdUþCK7þ /CK7þ in IC 53.76%a 13.86%a 2.36%a 1.09%a
EdUþCK7þ /CK7þ in UC 48.95%a 9.86%a 1.63%a 0.9%a
EdUþCK7 in UC 5.53% 2.82% 0.18% NA
EdUþp63þ /p63þ in BIC 27.62%a NA 1.36%a NA
EdUþp63þ /p63þ in UC 21.22%a NA 1.24% NA
EdUþp63 in SC 54.24% NA 4.62% NA
EdUþp63 in UC 12.57% NA 0.41%a NA
EdUþki67þ /ki67þ 23.24%a 2.7%a Neg NA
ki67þ in UC 56.92% 14.86% 1.79% NA
EdUþki67þ in UC 13.23% 0.4% Neg NA
EdUþCK20þ /CK20þ in SC 58.82%a 23.08%a 30.77%a,b 2.03%a
EdUþCK20þ /CK20þ in UC 2.39%a 2.13%a 0.88%a 0.06%a
CK20þ in UC 4.07% 9.22% 2.86% 3.00%
EdUþCK14þ /CK14þ in UC 2.62%a 1.27%a Neg Neg
CK14þ in UC 6.55% 32.28% 8.21% 0.79%
CD117þEdUþ /CD117þ in UC NA Neg Neg Neg
CD117 in UC NA Neg Neg Neg
CD117 in stroma NA 2.68% 0.56% NA
Urothelial cells¼UC; intermediate cells¼ IC; basal and intermediate cells¼BIC;
superﬁcial cells¼SC; Neg¼Negative, NA¼not analyzed.
a Percentage of double positive cells of the cell population with a particular
phenotype within a cell layer.
b Very few CK20þ cells in superﬁcial cell layer.
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Table 3
Summary of biomarkers in different cell layers from bladders obtained from animals of different ages.
Biomarker/cell layer E17 p5 1 month 3 months 6 months Mother
CK14/basal þþ þþ þ   
Colocalize with EdU/BrdU þ þ þ   
Ki67/basal þþþ þþ þ þ þ þ
Colocalize with EdU/BrdU þþ þ    
CD44/scattered cells þ     na
CD44/Basal membrane þ þ þ þ þ na
Colocalize with EdU/BrdU þ þ þ þ þ na
CD117/stroma  þ þ/   na
Colocalize with EdU/BrdU      na
Trop2/basal, intermediate þ þ þ þ þ na
Colocalize with EdU/BrdU þ þ þ þ þ na
p63/basal, intermediate þ þ þ þ þ þ
Colocalize with EdU/BrdU þ þ þ na na þ
CK7/intermediate þ þ þ na na þ
Colocalize with EdU/BrdU þ þ þ na na 
Lgr5/umbrella na þ na na na na
Colocalize with EdU/BrdU na na na na na na
CK20/umbrella þ þ þ þ þ þ
Colocalize with EdU/BrdU þ þ þ na þ 
Fig. 2. RC in bladders at E17. Preferential location of RC close to urethra ((a), (c), and (e)). RC present in umbrella cells (g), intermediate cells ((b), (h), and (j)), and basal cells
((h), (i), and (j)). Many RC proliferated ((c) and (d)). Homogeneous expression of Trop2 (j) and CD44 ((e) and (f)). Arrows indicate co-localized cells.
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RC in bladder from 6 months old mice
Urothelial RC were almost absent in bladders from 6 months
old mice and the percentage of RC in urothelium was 1 %. The
distribution of BrdU/EdU containing cells was similar to younger
animals and located along the urethra. The intensity of the BrdU/
EdU signal was still strong. RC were observed in all urothelial cell
layers, including in luminal (Fig. 5a–c), intermediate (Fig. 5d and e),
and basal (Fig. 5f) cell layers.
Discussion
This study suggests that slow cycling cells may be present in
superﬁcial cells of the bladder in adult animals, contrasting to the
common view that these cells are present in the basal cell layer
(Kurzrock et al., 2008). Additionally, slow cycling cells were
concentrated in the trigone, close to urethra. The conﬁnement to
this relatively small area is remarkable and contrasts with the
presence of adult stem cells/progenitor cells in other epithelia
Fig. 3. Bladder (a) and urethra (b) from p5 showing preferential location of RC in the trigone. Arrows indicate RC in the luminal (c), intermediate ((d) and (e)), and basal
((f) and (h)) cell layers. Homogeneous expression of Trop2 (e) and CD44 (g) in all epithelial cells and cells underneath the bladder, respectively. Ki67þEdUþ cells are
restricted to basal cells. Dash line indicates urethra in (a) and (b).
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where these cells appear to be evenly distributed (Gaisa et al.,
2011). To obtain cells for tissue engineering purposes, it therefore
seems advisable to harvest cells close to the trigone area of the
bladder.
For bladder tissue regeneration, and for large acellular con-
structs in general, acellular constructs may cause ﬁbrosis in the
central region (Atala, 2011). Stem cells combined with (biodegrad-
able) matrices may signiﬁcantly alter the perspective of tissue
engineering because repair and remodeling of tissues depends on
stem cells (Aboushwareb and Atala, 2008). In a landmark study in
patients who needed cystoplasty, engineering of bladder tissues
was described (Atala et al., 2006). Although the results were
encouraging, the promising efﬁcacy of the phase I study could
not be substantiated in the phase II study (Joseph et al., 2013).
Based on our study, isolation of urothelial cells from trigone area
may provide better chance of bladder regeneration.
Label retaining method is the ﬁrst step to label slow cycling cells
among all progenitor cells in the epithelia (Tsujimura et al., 2002;
Cotsarelis et al., 1989; Braun et al., 2003; Barker et al., 2007; Tumbar
et al., 2004). However, label-retaining cells do not necessarily
represent progenitor or stem cell populations. Immediately after
administration of label EdU/BrdU-positive cells will be present in all
actively dividing cells. Thus, the initial presence of a substantial
number of Ki67þ EdUþ cells (13%) was anticipated. As time
progresses and label is diluted out from more rapid (non-stem cells)
diving cells, label-retaining cells represent the more quiescent cells.
Thus, the BrdU or EdU retaining method is one of the accepted
methods to label the slow cycling cells.
Because we wanted to be certain that all potential progenitor
cells in the developing bladder were labeled, BrdU/EdU was injected
during the period when bladder development starts (around E10)
and before bladder development is ﬁnalized (in E14). EdU was
sparsely observed in bladder tissue from adults from group A
(receiving injections at E8/E9) and group B (receiving injections at
E10/E11). Most likely the injection time was too early and most cells,
including stem/progenitor cell have undergone too many division
cycles, diluting the label to undetectable levels. The fact that the
time of administration inﬂuenced the distribution of label retaining
cell is a reﬂection of the ongoing organogenesis, with the bladder
developing. Bladder development is most prominent on gestational
days E11–E13 (Mendelsohn 2009; Price et al., 2009). Indeed, the
amount of label retaining cells and label intensity was much higher
in offspring from group C (injection E12–E13), showing that results
of group C were most representative and informative for bladder
organogenesis. Surprisingly, Colopy et al. (2014) did not detect RC in
urothelium in one month old mice that had received BrdU between
E10 and E13. The lack of RC can be explained by the lower BrdU dose
in combination with shorter exposure time leading to lower BrdU
uptake in slow cycling cells. In our 2-day exposure regimen RC were
sparse in animals receiving label during E8–E11.
Fig. 4. Sections of bladder from 1 month old animals. RC are preferentially located in the trigone (a). LRC in luminal (b), intermediate ((c)–(e)), and basal cell layers (e). Strong
CK14 staining in basal cells of the urethra (i). Homogenous expression of CD44 in connective tissue (g). ki67 expression restricted to basal cells (h). Square dot dash line
indicates urethra in (a) and round dot dash line indicates lumen in (a), (c), (e), (f), (g), and (h).
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RC were located in all cell layers of murine urothelium when
animals received BrdU or EdU at P1 (new born) (Colopy et al.,
2014; Zhang et al., 2012). When animals received BrdU after P14
(up to adulthood), RC were predominately located in the basal cell
layer (Kurzrock et al., 2008; Colopy et al., 2014). Most likely BrdU
administrated at P14 and beyond incorporates in proliferating
(ki67þ) basal cells that dominate the proliferative response in
very young and adult animals. In our case labels were adminis-
tered during bladder organogenesis and incorporated labels were
diluted in rapidly and in slowly dividing cells. In agreement with
Kurzrock et al., proliferating cells (ki67þ) were exclusively present
in the basal cell layer of new born and adult animals, whereas
BrdU/EdU were distributed in other cell layers as well.
In rat bladders, β4 integrinþ basal cells were more clonogenic
and proliferative than β4 integrin-negative cells (Kurzrock et al.,
2008). β4 integrin expression was not observed in the mouse
bladders examined. Whether this is a species-speciﬁc marker for
slow-cycling cells remains to be established.
It is conceivable that a small population of progenitor cells is
present in the intermediate and superﬁcial cell layers. We
observed label-retaining cells, presumably progenitor cells, in all
three cell layers of the urothelium: EdU was detected in basal cells
(p63þ), in intermediate cells (p63þ CK7þ), and in superﬁcial
cells (CK20þ) at all ages. In bladders from 6 months old mice, the
percentage of superﬁcial cells containing EdU was 2% (3/148,
CK20þ EdUþ/CK20þ; 148 umbrella cells of a total of 4941
urothelial cells.). In agreement with our results, other studies have
also shown that progenitor cells can be located in the intermediate
cell layer and that these cells can produce superﬁcial cells or,
alternatively, superﬁcial cells can reprogram to basal stem cells
(Gandhi et al., 2013; Tata et al., 2013). Moreover, human supra-
basal and basal cells showed long term proliferation and the
capacity to form full urothelial cell layers and Colopy et al.
detected proliferating cells in intermediate and basal cell layers
in murine bladders (Wezel et al., 2014). Collectively this suggests
that two distinct progenitor cell populations may exist that resides
in the basal and intermediate cell layer and that these may be
responsible for basal/intermediate cells and umbrella cells, respec-
tively (Colopy et al., 2014; Castillo-Martin et al., 2010).
Shh-expressing basal cells of adult murine urothelium, pre-
sumably stem/progenitor cells, can differentiate to umbrella cells
(Shin et al., 2011). When isolated, labeled murine basal cells
demonstrated clonogenic capacity with the vast majority of large
colonies being comprised of labeled basal cells (Kurzrock et al.,
2008). However, intermediate and superﬁcial cell layers were not
tested. Moreover, in p63/ mouse basal cells are absent and the
bladder is lined with a single layer of umbrella cells, suggesting
that basal, intermediate, and superﬁcial (umbrella) cells are not
related hierarchically (Karni-Schmidt et al., 2011). In ΔNp63
animals murine basal cells were not essential for urothelial
differentiation (to produce superﬁcial cells) but did play a major
role in survival of progenitor cells during urothelial development
(Pignon et al., 2013; Cheng et al., 2006). Finally, a fate mapping
study of retinoid signaling in developing murine urothelium
showed that basal cells rarely produced intermediate or superﬁcial
cells (Gandhi et al., 2013). During embryogenesis progenitor cells
(Foxa2þ Upkþ p63þ Shhþ CK5) resided in the intermediate
cell layer; in adults in intermediate cells (Foxa2 Upkþ p63þ
Shhþ CK5) were identiﬁed as superﬁcial cell progenitors
(Gandhi et al., 2013). In view of this collective evidence and
considering that cells isolated from bladder washing or from urine
can produce all cell layers of the urothelium (Nagele et al., 2008;
Bharadwaj et al., 2011; Wu et al., 2011), it is likely that a small
population of progenitor cells is located superﬁcially.
In previous label-retaining studies animals received label-
ing compounds post natally four times and label was detected
Fig. 5. Sections of bladders from 6 months old animals. RC are present in all cell layers of the bladder, including luminal ((a)–(c)), intermediate ((d) and (e)), and basal
(f) cells. CD44 is expressed in the connective tissues supporting urothelial cells. Round dot dash line indicates lumen in (a), (d), (e) and (f).
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exclusively in the murine basal cell layer (Kurzrock et al., 2008).
Analysis of bladders from mother mice eight days after adminis-
tration of EdU demonstrated that EdU was only detectable in the
basal cell layer of the urothelium in agreement with these earlier
label-retaining studies (SI 2) (Kurzrock et al., 2008). This suggests
that progenitor cells in the basal cell layer divide more frequently
than progenitor cells in the intermediate and superﬁcial cell layers.
EdU retaining cells were not evenly distributed throughout the
bladder, but were concentrated in the bladder trigone. In addition,
the bladder trigone is associated with inﬂammatory and neoplastic
conditions (Palou et al., 2004; Paner et al., 2011). A rat bladder
study showed that the colony formation capacity of cells isolated
from the caudal bladder in the trigone was two-fold higher than
the colony formation capacity of cells from the cephalic bladder
(Nguyen et al., 2007). This suggests that the bladder trigone is
crucial in the maintenance of bladder progenitor cells.
EdU containing cells were observed up to 6 months after
injection. The number of retaining cells decreased steadily from
45% (E17) to 1% (6 months) (Table 2). The remaining 1% of EdU
containing cells may be bladder progenitor cells, but could also
represent quiescent non-progenitor cells. Functional studies are
needed to show whether this 1% of EdU labeled cells truly
represent the bladder progenitor cells.
Conclusion
In summary, we propose that slow cycling cells, most likely
representing progenitor cells of the bladder, reside mostly in the
trigone of the bladder and that they are distributed throughout all
urothelial cell layers. Understanding the geographic location of
slow cycling cells provides crucial information for tissue regen-
erative purposes in the future.
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